Nu Skin Enterprises announced the launch of its Prysm iO platform on April 2, 2026, making the device available to general consumers in the United States for $375. The launch marks the first time the company’s flagship AI‑powered wellness device is sold directly to end users rather than through its multi‑level marketing network.
Prysm iO is an AI‑driven system that measures carotenoid levels through a non‑invasive fingertip scan that takes about 15 seconds. The device uses the data to assess nutritional health and provide personalized supplement recommendations, creating a recurring subscription revenue stream for the company.
The launch signals a strategic shift toward a subscription‑based model and a broader consumer market. By offering the device directly to consumers, Nu Skin aims to reduce its reliance on the traditional MLM channel and capture higher margins from data‑driven wellness services. "Prysm iO represents a new frontier for personalized wellness and another critical milestone in our vision to become the world's leading intelligent beauty and wellness company, powered by our dynamic affiliate opportunity platform," said President and CEO Ryan Napierski.
Nu Skin’s Q4 2025 results showed revenue of $370.32 million, down 16.9% from $445.6 million in Q4 2024, and an EPS of $0.29, missing the consensus estimate of $0.30. Gross margin improved to 70.7% from 62.7% in the prior year, driven by a favorable product mix and cost control. "We are pleased to achieve fourth quarter results within our guidance range for both revenue and earnings per share. This past year was a pivotal year as we furthered our transformation toward becoming the world's leading intelligent beauty and wellness platform and laid the groundwork for our 2026 growth initiatives," Napierski said.
Investors focused on the earnings miss and weak guidance for Q1 2026 and the full year, which forecast revenue of $320‑$340 million and EPS of $0.10‑$0.20, below analyst expectations. The market reaction was tempered by the announcement that the new product would drive subscription uptake and long‑term growth, but the short‑term outlook remained cautious. "We are pleased with how we performed this year, growing earnings by more than 50% due to effective margin improvement and cost optimization amid top‑line pressures," CFO James D. Thomas added.
Nu Skin plans to launch Prysm iO in India later in 2026, and management expects the device to become a key driver of revenue growth by the end of the year. The company’s focus on AI and data analytics positions it to capture a larger share of the personalized wellness market while reducing dependence on its legacy MLM model.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.